RxDoctor Payments Data

Gisellis Orantes, NP

Adult Health · Bay Shore, NYNPI 1215650650

Payments from drug & device makers

$1,266in general payments, 2019–2025

Across 33 payments — averaging $38.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$318
  • Exact Sciences$255
  • Inspire Medical Systems, Inc.$190
  • Abbott$150
  • Novo Nordisk$112
  • Amgen$105
  • plus $137 from 4 others

What the payments were for

  • Food & beverage$1,266100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,266 in reported general payments places this provider in the 70th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$9,493
Medicare patients
40
Services billed
242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide26$33,234
JanuviaSitagliptin Phosphate25$29,881
MounjaroTirzepatide19$23,965
JardianceEmpagliflozin26$23,214
EliquisApixaban12$14,826
VascepaIcosapent Ethyl12$3,081
Albuterol Sulfate HfaAlbuterol Sulfate25$1,109
Levothyroxine Sodium86$1,094
Omeprazole83$954
Atorvastatin Calcium77$824
Metoprolol Succinate50$751
Amlodipine Besylate124$720
Metformin Hcl91$692
Glimepiride55$688
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide46$660

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$112$33,23426 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,828 adult health providers in New York.

Other adult health in Bay Shore

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →